In conclusion, this case report demonstrates that naltrexone-bupropion treatment can effectively reduce weight and improve patient-reported hyperphagia and quality of life in the long term in a patient with severe obesity and hyperphagia due to MC4R deficiency. The gene discussed is MC4R; the disease is Obesity.